Barrett Mooney Joins DIH Holding US, Inc. as Latest Board Addition, Bringing Deep Manufacturing and AI Expertise

DIH Holding US, Inc. (NASDAQ: DHAI), a leading global developer of advanced robotic rehabilitation systems that leverage interactive visual stimulation for clinical research and intensive functional training, has welcomed Barrett Mooney, Ph.D., to its Board of Directors. This appointment marks a significant move to strengthen the company’s leadership team as it continues expanding its presence in the rapidly growing rehabilitation technology sector.

Executive Track Record and Strategic Vision

Dr. Mooney brings substantial operational credentials to the role, with a distinguished career focused on scaling technology-driven and manufacturing-intensive enterprises. His professional portfolio demonstrates a consistent pattern of success in managing complex organizations through significant transformations. Most notably, he served as CEO and Chairman of a NYSE American-listed aerospace and defense firm, where he orchestrated multiple major acquisitions and successfully navigated the company’s transition from private to public markets.

His entrepreneurial achievements include co-founding HydroBio Inc., a technology company specializing in satellite-driven image analytics for agricultural optimization. In May 2017, the company was acquired by The Climate Corporation. Following this transaction, Dr. Mooney remained with the acquired entity—a Monsanto subsidiary (now owned by Bayer)—where he led teams in developing artificial intelligence solutions to enhance agricultural productivity and redesigned organizational structures to boost seed sales efficiency.

Expertise in Emerging Technologies

Beyond his corporate leadership roles, Dr. Mooney has built a reputation for strategic advisory work with high-growth technology companies, particularly those focused on complex manufacturing and supply chain optimization. His involvement with CropIn Technology Solutions exemplifies this focus, where he directed the international rollout of AI-powered decision support systems for commodity and supply chain management.

Additional career highlights include technology team leadership within agricultural retail organizations, venture capital advisory roles, and work as an energy efficiency engineer. Dr. Mooney holds a Doctor of Philosophy in Engineering from the University of Florida.

Company Leadership Perspective

Jason Chen, CEO of DIH, expressed enthusiasm about the appointment: “Welcoming Dr. Barrett Mooney to our Board brings tremendous value as we execute our strategic growth initiatives in rehabilitation robotics. His demonstrated ability to scale complex manufacturing businesses, coupled with his hands-on experience leading companies through major acquisitions and public market transitions, positions him as an ideal addition to our governance structure. His deep familiarity with AI-driven innovations and operational excellence will prove invaluable as we advance our market position.”

Dr. Mooney commented on his new role: “Joining DIH’s Board represents an exciting opportunity to contribute to advancing rehabilitation outcomes through cutting-edge robotic technology. The company’s distinctive integration of robotics with interactive visual stimulation addresses substantial market needs and offers compelling prospects for transforming how patients experience rehabilitation. I look forward to collaborating with the executive team and board colleagues to drive continued innovation and create sustainable shareholder value.”

Governance Enhancement

The expanded Board of Directors now comprises seven members, with five serving as independent directors. This composition reinforces DIH’s commitment to robust corporate governance standards and provides enhanced oversight as the company pursues its strategic objectives.

About DIH’s Market Position

DIH operates as a transformative provider of rehabilitation solutions, consolidating a historically fragmented and labor-intensive industry through strategic acquisitions and technological integration. The company’s mission centers on “Delivering Inspiration & Health” to millions of individuals living with disabilities and functional impairments. Its portfolio includes advanced robotic devices designed for patients experiencing walking impairments, balance deficiencies, and arm or hand functional limitations, all enhanced through integrated visual stimulation for optimal clinical outcomes.

Forward-Looking Considerations

This announcement contains forward-looking statements subject to risks and uncertainties that may cause actual results to differ materially from projections. Key factors include general economic conditions, DIH’s ability to achieve revenue targets, realization of anticipated business combination benefits, and access to additional capital resources. The company makes no commitment to update these statements at future dates.